⌘K

Home/Filings/4/0001209191-20-049014

4//SEC Filing

D'Onofrio Matthew J 4

Accession 0001209191-20-049014

CIK 0001403708other

View on SEC.gov Company Profile

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 8:30 AM ET

Size

4.8 KB

Accession

0001209191-20-049014

Insider Transaction Report

Form 4

Period: 2020-09-01

Evoke Pharma IncEVOK

D'Onofrio Matthew J

Exec VP, Chief Bus. Officer

Transactions

Other
Common Stock
2020-09-01$1.05/sh+20,238$21,250→ 283,997 total

Footnotes (1)

[F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions exempt under Rule 16b-3(c).

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Evoke Pharma Inc

CIK 0001403708

Entity typeother

Related Parties

1

filerCIK 0001578770

Filing Metadata

Form type: 4
Filed: Sep 1, 8:00 PM ET
Accepted: Sep 2, 8:30 AM ET
Size: 4.8 KB

View on SEC.gov